Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.32
GB's Cash to Debt is ranked higher than
53% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. GB: 0.32 )
GB' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.32

Equity to Asset 0.64
GB's Equity to Asset is ranked higher than
71% of the 451 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. GB: 0.64 )
GB' s 10-Year Equity to Asset Range
Min: 0.28   Max: 0.75
Current: 0.64

0.28
0.75
Interest Coverage 5.45
GB's Interest Coverage is ranked lower than
53% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. GB: 5.45 )
GB' s 10-Year Interest Coverage Range
Min: 0.05   Max: 9.31
Current: 5.45

0.05
9.31
F-Score: 8
Z-Score: 4.09
M-Score: -2.76
WACC vs ROIC
13.60%
7.59%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.00
GB's Operating margin (%) is ranked higher than
83% of the 465 Companies
in the Global Medical Devices industry.

( Industry Median: 5.96 vs. GB: 11.00 )
GB' s 10-Year Operating margin (%) Range
Min: 0.2   Max: 17.66
Current: 11

0.2
17.66
Net-margin (%) 8.06
GB's Net-margin (%) is ranked higher than
82% of the 465 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. GB: 8.06 )
GB' s 10-Year Net-margin (%) Range
Min: -2.87   Max: 10.76
Current: 8.06

-2.87
10.76
ROE (%) 9.55
GB's ROE (%) is ranked higher than
81% of the 450 Companies
in the Global Medical Devices industry.

( Industry Median: 5.07 vs. GB: 9.55 )
GB' s 10-Year ROE (%) Range
Min: -2.39   Max: 10.53
Current: 9.55

-2.39
10.53
ROA (%) 6.05
GB's ROA (%) is ranked higher than
81% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. GB: 6.05 )
GB' s 10-Year ROA (%) Range
Min: -1.07   Max: 6.21
Current: 6.05

-1.07
6.21
ROC (Joel Greenblatt) (%) 23.84
GB's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 479 Companies
in the Global Medical Devices industry.

( Industry Median: 8.65 vs. GB: 23.84 )
GB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.38   Max: 52.65
Current: 23.84

0.38
52.65
Revenue Growth (3Y)(%) 5.40
GB's Revenue Growth (3Y)(%) is ranked higher than
76% of the 345 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. GB: 5.40 )
GB' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.2   Max: 30.3
Current: 5.4

0.2
30.3
EBITDA Growth (3Y)(%) -4.50
GB's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. GB: -4.50 )
GB' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -7.6   Max: 30.6
Current: -4.5

-7.6
30.6
EPS Growth (3Y)(%) 1.00
GB's EPS Growth (3Y)(%) is ranked higher than
76% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. GB: 1.00 )
GB' s 10-Year EPS Growth (3Y)(%) Range
Min: -20   Max: 146.6
Current: 1

-20
146.6
» GB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

GB Guru Trades in Q1 2014

Joel Greenblatt 138,990 sh (New)
Jim Simons 112,290 sh (+386.1%)
Steven Cohen Sold Out
Mario Gabelli 243,600 sh (-2.79%)
Chuck Royce 70,000 sh (-15.66%)
Diamond Hill Capital 504,785 sh (-17.86%)
» More
Q2 2014

GB Guru Trades in Q2 2014

Joel Greenblatt 250,635 sh (+80.33%)
Chuck Royce 107,000 sh (+52.86%)
Jim Simons 161,300 sh (+43.65%)
Mario Gabelli 227,100 sh (-6.77%)
Diamond Hill Capital 414,221 sh (-17.94%)
» More
Q3 2014

GB Guru Trades in Q3 2014

Ken Fisher 609,572 sh (New)
Paul Tudor Jones 18,514 sh (New)
Joel Greenblatt 264,417 sh (+5.5%)
Diamond Hill Capital 411,516 sh (-0.65%)
Mario Gabelli 194,100 sh (-14.53%)
Jim Simons 107,100 sh (-33.6%)
Chuck Royce 60,408 sh (-43.54%)
» More
Q4 2014

GB Guru Trades in Q4 2014

Joel Greenblatt 296,657 sh (+12.19%)
Ken Fisher 616,332 sh (+1.11%)
Diamond Hill Capital 412,640 sh (+0.27%)
Mario Gabelli 173,600 sh (-10.56%)
Chuck Royce 42,501 sh (-29.64%)
Paul Tudor Jones 9,328 sh (-49.62%)
Jim Simons 53,900 sh (-49.67%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2014-09-30 New Buy0.06%$42.95 - $51 $ 53.1414%609572
Joel Greenblatt 2014-06-30 Add 80.33%0.07%$44.4 - $49.94 $ 53.1413%250635
Joel Greenblatt 2014-03-31 New Buy0.1%$40.37 - $46.98 $ 53.1421%138990
Joel Greenblatt 2012-06-30 Sold Out 0.09%$20.5 - $24.73 $ 53.14140%0
Joel Greenblatt 2012-03-31 Reduce -22.75%0.03%$21.51 - $25.49 $ 53.14138%41455
Mario Gabelli 2012-03-31 Add 53.3%0.02%$21.51 - $25.49 $ 53.14138%320400
Joel Greenblatt 2011-12-31 Add 21.58%0.02%$18.86 - $22.74 $ 53.14153%53665
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.50
GB's P/E(ttm) is ranked higher than
87% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 98.30 vs. GB: 27.50 )
GB' s 10-Year P/E(ttm) Range
Min: 11.04   Max: 575.08
Current: 27.5

11.04
575.08
Forward P/E 19.72
GB's Forward P/E is ranked higher than
90% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 19.72 )
N/A
PE(NRI) 27.50
GB's PE(NRI) is ranked higher than
86% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 80.70 vs. GB: 27.50 )
GB' s 10-Year PE(NRI) Range
Min: 11.04   Max: 534
Current: 27.5

11.04
534
P/B 2.20
GB's P/B is ranked higher than
83% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. GB: 2.20 )
GB' s 10-Year P/B Range
Min: 0.97   Max: 3.4
Current: 2.2

0.97
3.4
P/S 2.00
GB's P/S is ranked higher than
80% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 3.74 vs. GB: 2.00 )
GB' s 10-Year P/S Range
Min: 0.78   Max: 4.17
Current: 2

0.78
4.17
PFCF 18.70
GB's PFCF is ranked higher than
93% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 18.70 )
GB' s 10-Year PFCF Range
Min: 6.12   Max: 169.91
Current: 18.7

6.12
169.91
POCF 14.81
GB's POCF is ranked higher than
90% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 73.76 vs. GB: 14.81 )
GB' s 10-Year POCF Range
Min: 5.14   Max: 26.7
Current: 14.81

5.14
26.7
EV-to-EBIT 20.32
GB's EV-to-EBIT is ranked higher than
86% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 67.21 vs. GB: 20.32 )
GB' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 3207.3
Current: 20.32

8.3
3207.3
PEG 3.40
GB's PEG is ranked higher than
93% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 3.40 )
GB' s 10-Year PEG Range
Min: 0.71   Max: 920.69
Current: 3.4

0.71
920.69
Shiller P/E 56.20
GB's Shiller P/E is ranked higher than
86% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 56.20 )
GB' s 10-Year Shiller P/E Range
Min: 22.96   Max: 60.88
Current: 56.2

22.96
60.88
Current Ratio 3.63
GB's Current Ratio is ranked higher than
79% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. GB: 3.63 )
GB' s 10-Year Current Ratio Range
Min: 1.6   Max: 8.42
Current: 3.63

1.6
8.42
Quick Ratio 2.20
GB's Quick Ratio is ranked higher than
73% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. GB: 2.20 )
GB' s 10-Year Quick Ratio Range
Min: 0.79   Max: 6.93
Current: 2.2

0.79
6.93
Days Inventory 98.37
GB's Days Inventory is ranked higher than
85% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 158.55 vs. GB: 98.37 )
GB' s 10-Year Days Inventory Range
Min: 86   Max: 121.04
Current: 98.37

86
121.04
Days Sales Outstanding 66.31
GB's Days Sales Outstanding is ranked higher than
79% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 78.72 vs. GB: 66.31 )
GB' s 10-Year Days Sales Outstanding Range
Min: 40.02   Max: 68.3
Current: 66.31

40.02
68.3

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.82
GB's Price/Tangible Book is ranked higher than
68% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. GB: 7.82 )
GB' s 10-Year Price/Tangible Book Range
Min: 5.43   Max: 74.81
Current: 7.82

5.43
74.81
Price/DCF (Projected) 1.51
GB's Price/DCF (Projected) is ranked higher than
94% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 1.51 )
GB' s 10-Year Price/DCF (Projected) Range
Min: 0.52   Max: 1.66
Current: 1.51

0.52
1.66
Price/Median PS Value 1.53
GB's Price/Median PS Value is ranked higher than
67% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 1.32 vs. GB: 1.53 )
GB' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 3.99
Current: 1.53

0.6
3.99
Price/Peter Lynch Fair Value 3.47
GB's Price/Peter Lynch Fair Value is ranked higher than
96% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 3.47 )
GB' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74   Max: 88.62
Current: 3.47

0.74
88.62
Price/Graham Number 3.22
GB's Price/Graham Number is ranked higher than
84% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GB: 3.22 )
GB' s 10-Year Price/Graham Number Range
Min: 1.97   Max: 14.44
Current: 3.22

1.97
14.44
Earnings Yield (Greenblatt) 4.90
GB's Earnings Yield (Greenblatt) is ranked higher than
86% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. GB: 4.90 )
GB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 12
Current: 4.9

0.1
12
Forward Rate of Return (Yacktman) 8.45
GB's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 5.16 vs. GB: 8.45 )
GB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.6   Max: 27
Current: 8.45

3.6
27

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WGB.Germany,
Greatbatch, Inc is a Delaware corporation was incorporated on July 11, 1997. The Company designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group. Greatbatch Medical designs and manufactures products where Greatbatch either owns the intellectual property or has unique manufacturing and assembly expertise. Its products include medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets among others. The Greatbatch Medical segment also offers value-added assembly and design engineering services for medical devices that utilize its component products.. QiG segment develops medical device systems for some of healthcare's challenges and reflects Greatbatch's strategic evolution of its product offerings. Through the research and development professionals in QiG, the Company is now investing in three areas namely new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies to grow a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical. The Company's customers include large multi-national original equipment manufacturers. The Company is subject to direct governmental regulation including the laws and regulations generally applicable to all businesses in the jurisdictions in which it operates.
» More Articles for GB

Headlines

Articles On GuruFocus.com
BlackBerry Seems To Be Making The Right Moves Mar 08 2014 
Diamond Hill Capital Buys EOG, BR, GB, TEVA, BGS, IWD, HCC Jan 20 2011 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 09 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 10 2010 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 10 2009 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 11 2009 
Greatbatch, Inc. Reports Second Quarter 2009 Results Aug 04 2009 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2009 


More From Other Websites
Greatbatch Q4 Earnings Top on Solid Margins, Revenues Lag - Analyst Blog Feb 25 2015
Greatbatch tops 4Q profit forecasts Feb 24 2015
Greatbatch tops 4Q profit forecasts Feb 24 2015
Greatbatch Inc Earnings Call scheduled for 5:00 pm ET today Feb 24 2015
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 24 2015
Greatbatch, Inc. Reports 2014 Fourth Quarter and Full Year Results Feb 24 2015
Q4 2014 Greatbatch Inc Earnings Release - After Market Close Feb 24 2015
Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog Feb 20 2015
Stock Traders Get a Do-Over With Stock Indexes Flat in 2015 Feb 06 2015
Can GrubHub (GRUB) Keep Earnings Streak Alive in Q4? - Analyst Blog Feb 04 2015
Greatbatch, Inc. to Host Q4 2014 Earnings Conference Call Jan 27 2015
Greatbatch (GB) Rides High on Strategic Investments - Analyst Blog Jan 22 2015
Greatbatch Inc. (GB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Jan 21 2015
Greatbatch Reports Preliminary 2014 Results, Guides 2015 - Analyst Blog Jan 16 2015
Greatbatch, Inc. Provides Preliminary 2014 Results and 2015 Guidance Jan 15 2015
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 15 2015
Greatbatch, Inc. Provides Preliminary 2014 Results and 2015 Guidance Jan 15 2015
GREATBATCH, INC. Financials Nov 19 2014
GREATBATCH, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2014
Greatbatch Beats Q3 Earnings Estimates; Upgrades '14 View Oct 31 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK